Optimization of Treatment Geometry to Reduce Normal Brain Dose in Radiosurgery of Multiple Brain Metastases with Single-Isocenter Volumetric Modulated Arc Therapy.
Treatment of patients with multiple brain metastases using a single-isocenter volumetric modulated arc therapy (VMAT) has been shown to decrease treatment time with the tradeoff of larger low dose to the normal brain tissue. We have developed an efficient Projection Summing Optimization Algorithm to optimize the treatment geometry in order to reduce dose to normal brain tissue for radiosurgery of multiple metastases with single-isocenter VMAT. The algorithm: (a) measures coordinates of outer boundary points of each lesion to be treated using the Eclipse Scripting Application Programming Interface, (b) determines the rotations of couch, collimator, and gantry using three matrices about the cardinal axes, (c) projects the outer boundary points of the lesion on to Beam Eye View projection plane, (d) optimizes couch and collimator angles by selecting the least total unblocked area for each specific treatment arc, and (e) generates a treatment plan with the optimized angles. The results showed significant reduction in the mean dose and low dose volume to normal brain, while maintaining the similar treatment plan qualities on the thirteen patients treated previously. The algorithm has the flexibility with regard to the beam arrangements and can be integrated in the treatment planning system for clinical application directly.
Department of Radiation Oncology, Henry Ford Health System, MI, USA.
Qixue
Q
Wu
Department of Radiation Oncology, Henry Ford Health System, MI, USA.
Karen Chin
KC
Snyder
Department of Radiation Oncology, Henry Ford Health System, MI, USA.
Chang
C
Liu
Department of Radiation Oncology, Henry Ford Health System, MI, USA.
Yimei
Y
Huang
Department of Radiation Oncology, Henry Ford Health System, MI, USA.
Bo
B
Zhao
Department of Radiation Oncology, Henry Ford Health System, MI, USA.
Indrin J
IJ
Chetty
Department of Radiation Oncology, Henry Ford Health System, MI, USA.
Ning
N
Wen
J Neurosurg. 2001 Jun;94(6):899-904
11409517
Int J Radiat Oncol Biol Phys. 2001 Dec 1;51(5):1313-9
11728692
Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):419-24
16226848
Med Phys. 2008 Jan;35(1):310-7
18293586
Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):996-1001
19783374
Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):296-302
19836151
Radiat Oncol. 2010 Sep 13;5:77
20836871
Med Phys. 2010 Aug;37(8):4146-54
20879575
J Neurosurg. 2011 Jun;114(6):1580-4
21375377
Radiat Oncol. 2011 May 15;6:48
21575163
Med Dosim. 2012 Spring;37(1):31-6
21705211
Med Phys. 2011 Nov;38(11):5863-72
22047350
CNS Oncol. 2013 Mar;2(2):181-93
24273642
Pract Radiat Oncol. 2012 Oct-Dec;2(4):306-313
24674169
Neurosurgery. 2014 Oct;75(4):409-17; discussion 417-8
24871143
Radiother Oncol. 2014 Jul;112(1):128-32
24997990
J Neurosurg. 2014 Dec;121 Suppl:51-9
25434937
Med Phys. 2016 May;43(5):2527
27147363
Med Phys. 2012 Jun;39(6Part20):3854
28517544
J Radiosurg SBRT. 2011;1(2):117-122
29296305
Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):1055-63
8985027
Radiother Oncol. 1997 Jun;43(3):275-80
9215787
Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):485-90
9231670
Acta Neurochir Suppl. 1997;68:118-23
9233426